AmeriPath Presents At the 2000 U.S. Bancorp Piper Jaffray Conference; James C. New, Chairman & CEO, June 13, 2000 at 1:00 p.m. EDT.Business Editors/Health & Medical Writer RIVIERA BEACH Riviera Beach (rəvēr`ə), resort city (1990 pop. 27,639), Palm Beach co., SE Fla., on Lake Worth (a lagoon); inc. 1922. Research and development firms are located in the growing city. , Fla.--(BUSINESS WIRE)--June 13, 2000 AmeriPath, Inc. (Nasdaq:PATH), the largest physician and laboratory company focused on providing high quality anatomic pathology diagnostic and healthcare information services See Information Systems. to physicians, hospitals, national clinical laboratories, and managed care organizations, announced that Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , James C. New, will present at the 2000 U.S. Bancorp  This article or section needs copy editing for grammar, style, cohesion, tone and/or spelling.You can assist by [ editing it] now. Piper Jaffray Piper Jaffray & Co. (NYSE: PJC), often shortened to just Piper Jaffray or PiperJaffray, is a U.S. middle-market investment banking firm based in Minneapolis, Minnesota and is a focused on delivering financial advice, investment products and transaction execution Investor Conference in Minneapolis, Minnesota today at 1:00 p.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT . The Company operates in 13 states and employs 296 pathologists who provide medical services through 30 outpatient pathology laboratories, 164 hospital inpatient laboratories, and 47 outpatient surgery centers. AmeriPath annually diagnoses 2.5 million biopsies and 1.7 million cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. specimens. AmeriPath's Chairman and CEO, James C. New, commented, "In the year 2000, AmeriPath will focus on enhancing same store growth by continuing to expand both its Center for Advanced Diagnostics, which performs esoteric laboratory testing, and the Academy of Dermatopathology, an international dermatopathology education center and outpatient dermatopathology lab, and by expanding its national clinical laboratory contracts. AmeriPath also plans to increase its presence in urology urology Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones. , gasteroenterology and oncology testing markets." Through March 31, 2000, AmeriPath's earnings have been in line with, or exceeded the consensus of the financial analysts' expectations for nine consecutive quarters. This consistency reflects favorably on management's ability to execute it's plan and on the stability of the operating model in the turbulent health care sector. Additional information regarding AmeriPath can be found on the Company's website at www.ameripath.com. This release contains certain forward-looking statements regarding AmeriPath, including its operations and prospects. Past performance is not necessarily indicative of future results. In addition, AmeriPath's actual results could differ materially from the results anticipated in these forward-looking statements as a result of uncertainties, including risks relating to demand, pricing, government regulation, payments and reimbursement, changes on reimbursement coding guidelines, dependence upon contracts and pathologists, acquisitions and affiliations, integration of acquired practices, the market for pathology services, competition, technology and other factors identified in AmeriPath's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion